                         SEQUENCE LISTING

<110>  Novartis AG
       Basson, Craig
       Thuren, Tom
       Foo, Shi Yin
       Fishman, Mark
 
<120>  Use of IL1-beta binding antibodies

<130>  PAT055428-WO-PCT

<140>  Herewith
<141>  Herewith

<150>  61/727334
<151>  2012-11-16

<160>  8    

<170>  PatentIn version 3.5

<210>  1
<211>  118
<212>  PRT
<213>  homo sapiens

<400>  1

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Val Tyr 
            20                  25                  30          


Gly Met Asn Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val 
        35                  40                  45              


Ala Ile Ile Trp Tyr Asp Gly Asp Asn Gln Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Gln Met Asn Gly Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Asp Leu Arg Thr Gly Pro Phe Asp Tyr Trp Gly Gln Gly Thr 
            100                 105                 110         


Leu Val Thr Val Ser Ser 
        115             


<210>  2
<211>  107
<212>  PRT
<213>  homo sapiens

<400>  2

Glu Ile Val Leu Thr Gln Ser Pro Asp Phe Gln Ser Val Thr Pro Lys 
1               5                   10                  15      


Glu Lys Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Gly Ser Ser 
            20                  25                  30          


Leu His Trp Tyr Gln Gln Lys Pro Asp Gln Ser Pro Lys Leu Leu Ile 
        35                  40                  45              


Lys Tyr Ala Ser Gln Ser Phe Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Asn Ser Leu Glu Ala 
65                  70                  75                  80  


Glu Asp Ala Ala Ala Tyr Tyr Cys His Gln Ser Ser Ser Leu Pro Phe 
                85                  90                  95      


Thr Phe Gly Pro Gly Thr Lys Val Asp Ile Lys 
            100                 105         





<210>  3
<211>  5
<212>  PRT
<213>  HOMO SAPIENS

<400>  3

Val Tyr Gly Met Asn 
1               5   


<210>  4
<211>  17
<212>  PRT
<213>  HOMO SAPIENS

<400>  4

Ile Ile Trp Tyr Asp Gly Asp Asn Gln Tyr Tyr Ala Asp Ser Val Lys 
1               5                   10                  15      


Gly 
    


<210>  5
<211>  6
<212>  PRT
<213>  HOMO SAPIENS

<400>  5

Asp Leu Arg Thr Gly Pro 
1               5       


<210>  6
<211>  11
<212>  PRT
<213>  HOMO SAPIENS

<400>  6

Arg Ala Ser Gln Ser Ile Gly Ser Ser Leu His 
1               5                   10      


<210>  7
<211>  6
<212>  PRT
<213>  HOMO SAPIENS

<400>  7

Ala Ser Gln Ser Phe Ser 
1               5       


<210>  8
<211>  7
<212>  PRT
<213>  HOMO SAPIENS

<400>  8

His Gln Ser Ser Ser Leu Pro 
1               5           


